InfuSystem Holdings

INFU

Market cap $214M

My coverage for InfuSystem continues, focusing on recent developments and strategic positioning. INFU has made key operational improvements, has solid growth initiatives, and has the potential for continued strong revenue and earnings gains. InfuSystem's above-average growth has the potential to drive the stock for above-average long-term gains.

ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Participate at 38th Annual ROTH Conference on March 23, 2026.

InfuSystem Holdings, Inc. (INFU) Q4 2025 Earnings Call Transcript

InfuSystems Holdings, Inc. (INFU) came out with quarterly earnings of $0.1 per share, beating the Zacks Consensus Estimate of $0.07 per share. This compares to earnings of $0.04 per share a year ago.

ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Announces Financial Results for Fourth Quarter and Full Year 2025.

ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026.

InfuSystem: Regulatory Backed Market Catalyst

ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--Ambulatory Infusion Pumps used in Pain Management Business by InfuSystem to Receive Separate Payment Under NOPAIN Act Starting January 1, 2026.

InfuSystem Holdings offers strong growth potential and appears attractively valued after reporting positive Q3 2025 earnings results. INFU's Patient Services segment, especially oncology and wound care, is driving revenue growth, while Device Solutions faced a temporary decline. Margin improvements, new contracts, and the Apollo acquisition are enhancing profitability and expanding INFU's market share and efficiency.

ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Participate at 16th Annual Craig-Hallum Alpha Select Conference on November 18, 2025.